首页> 外文期刊>Urology >Management of abnormal postvoid residual urine in children with dysfunctional voiding.
【24h】

Management of abnormal postvoid residual urine in children with dysfunctional voiding.

机译:功能异常排尿患儿的异常后遗尿的处理。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To evaluate the effect of biofeedback therapy on the residual urine volume in children with dysfunctional voiding. METHODS: This prospective study was conducted in children with dysfunctional voiding associated with abnormal postvoid residual urine (PVR) from June 2002 to 2007. The children were divided randomly into 2 groups. Group 1 was treated with standard urotherapy combined with biofeedback therapy and group 2 was treated with only standard urotherapy. The outcomes of uroflow-electromyography pattern, urinary tract infection (UTI), and PVR were recorded before and at the end of sixth month of treatment. RESULTS: A total of 94 patients were enrolled in this study. Groups 1 and 2 consisted of 62 and 32 patients, respectively. The voiding pattern became normal in 80.6% (50/62) and 56.2% (18/32) of patients in groups 1 and 2, respectively. The PVR resolved in 40 of 62 (64.5%) patients in group 1 and in 11 of 32 (34.4%) children in group 2. Before the treatment, UTI was noted in 22.5% of patients (14/62) in group 1 and 21.8% of patients (7/32) in group 2. After the treatment, UTI was observed in 3.2% of patients (2/62) and in 9.3% (3/32) of patients in groups 1 and 2, respectively. Although both treatment modalities changed the voiding pattern, rate of febrile UTI, and PVR positively, these outcomes were better in a combination group. CONCLUSIONS: The combination of standard urotherapy with the biofeedback therapy improved the results significantly.
机译:目的:评估生物反馈疗法对排尿障碍的儿童剩余尿量的影响。方法:这项前瞻性研究于2002年6月至2007年对伴有异常的便后残留尿(PVR)的功能性排尿障碍的儿童进行。将儿童随机分为2组。第1组采用标准尿路疗法结合生物反馈疗法治疗,第2组仅采用标准尿路疗法治疗。在治疗的第六个月之前和结束时记录尿流-肌电图模式,尿路感染(UTI)和PVR的结果。结果:本研究共纳入94例患者。第1组和第2组分别由62例和32例患者组成。第1组和第2组中分别有80.6%(50/62)和56.2%(18/32)的患者排尿模式恢复正常。第1组的62例患者中有40例(64.5%)PVR消退,第2组的32例儿童中有11例(34.4%)的PVR消退。在治疗之前,第1组的22.5%的患者(14/62)观察到了UTI。第2组的患者占21.8%(7/32)。治疗后,第1组和第2组的患者分别占3.2%(2/62)和9.3%(3/32)的UTI。尽管两种治疗方式均积极改变了排尿模式,高热性尿路感染和PVR,但联合治疗组的这些结果更好。结论:标准尿路疗法与生物反馈疗法相结合可显着改善结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号